OptimizeRx Corp
OPRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$93.45M
Close$
$6.04
33% upside
Current Fair Value
33% upsideUndervalued by 33% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $93.45 Million |
|---|---|
| Enterprise Value | $97.67 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.28 |
| Beta | 1.1 |
| Outstanding Shares | 18,761,622 |
Return
| Return on Equity | 5.27% |
|---|---|
| Return on Assets | 4.09% |
| Return on Invested Capital | 2.80% |
Valuation & Multiples
| P/E Ratio | 13.67 |
|---|---|
| PEG | -17.64 |
| Price to Sales | 0.91 |
| Price to Book Ratio | 0.76 |
| Enterprise Value to Revenue | 0.91 |
| Enterprise Value to EBIT | 22.23 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$0.01
Average shareholder expectationRevenue Estimate
$18.74 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$20.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4613▲ 46.13% |
|---|---|
| Total Calls | 104,700▼ 9.66% |
| Total Puts | 48,300▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 73.00%▲ 0.95% |
|---|---|
| Total Invested | $85.79M▼ 47.67% |
| Investors Holding | 131▼ 1.00% |
ESG Score
No data
About OptimizeRx Corp
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary ne...